Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa (Q82962367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

cervix uterine cancer

1 reference

Arthi Vijayaraghavan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Molly Efrusy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Gerhard Lindeque

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Greta Dreyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Christopher Santas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

11 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

377-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Spectrum of AIDS-associated malignant disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Human papillomavirus (HPV) infection in Southern Africa: prevalence, immunity, and vaccine prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Natural history of cervicovaginal papillomavirus infection in young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cost-effectiveness of a potential vaccine for human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Human papillomavirus infection in human immunodeficiency virus-seropositive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

The 2001 Bethesda System: terminology for reporting results of cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cost-effectiveness of cervical-cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Cervical cancer screening following prophylactic human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

Generalisability in economic evaluation studies in healthcare: a review and case studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.030

10.1016/J.YGYNO.2008.08.030

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19081611%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference